Indication

Letterer-Siwe disease

Letterer-Siwe disease is an acute, severe, multisystem form of Langerhans cell histiocytosis characterized by the clonal proliferation and widespread tissue infiltration of pathologic dendritic mononuclear cells. Read more about Letterer-Siwe disease

4 drugs 4 manufacturers

Advertisement

Drugs that treat it

Common Letterer-Siwe disease therapies.

Showing 1–4 of 4 drugs

Filter & compare in the drug finder →Opens the drug finder with Letterer-Siwe disease preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Letterer-Siwe disease.

Letterer-Siwe disease is an acute, severe, multisystem form of Langerhans cell histiocytosis characterized by the clonal proliferation and widespread tissue infiltration of pathologic dendritic mononuclear cells.

It primarily affects infants and children younger than two years of age, presenting as a disseminated disorder involving high-risk organ systems.

Clinically, it manifests with constitutional symptoms such as fever and failure to thrive, alongside a characteristic scaly or purpuric seborrheic-like cutaneous eruption, lymphadenopathy, hepatosplenomegaly, cytopenias from bone marrow infiltration, and potential pulmonary or skeletal involvement.

Without prompt systemic intervention, this disseminated histiocytic proliferation carries a high risk of rapidly progressive organ dysfunction and significant mortality.

Personalize your experience

Follow Letterer-Siwe disease and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it